Ciprofloxacin

• ANTIBIOBONTA - Assessment of the interest of a peri-operative antibiotic strategy applied to patients with asymptomatic bacteriuria undergoi… Pending
  2024-515107-19-00 Phase III 1 country Centre Hospitalier Universitaire De Lille
• ATLAS trial Pending
  2024-517233-40-00 Phase IV 1 country Amsterdam UMC Stichting; Proctos kliniek
• STUDY TO FIND OUT WHETHER A SHORTER ANTIBIOTIC TREATMENT (7 DAYS) IS AS EFFECTIVE AND SAFE AS THE USUAL ONE (14 DAYS) IN PATIENTS WITH AN IN… Pending
  2025-523120-53-00 Phase III/IV 1 country Bellvitge University Hospital; Fundacio Institut D'Investigacio Biomedica De Bel…
• Multicenter clinical trial on the effectiveness and safety of outpatient treatment of acute uncomplicated diverticulitis without antibiotics… Pending
  2025-523121-17-00 Phase IV 1 country Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
• Phase IV, randomized, open label, parallel groups clinical trial for evaluating the early Stop of antibiotic Treatment in high-risk febrile … Pending
  2025-524264-38-00 Phase IV 1 country Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
• Shorter versus longer antibiotic treatment for serious urinary tract infections in men Pending
  2025-524703-76-00 Phase III 1 country UZ Brussel
• LIBRETTO: Stimulan™ Local Antibiotic Delivery System Versus 4-Week Systemic Antibiotic Therapy for Diabetic Foot Osteomyelitis – A Prospecti… Pending
  2025-524723-52-00 Phase III 1 country Pirkanmaan hyvinvointialue
• Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects with Moderately to Severely Active Crohn's Dis… Recruiting
  2023-509618-12-00 Phase III 7 countries AbbVie Deutschland GmbH & Co. KG
• Efficacy and safety of 7 versus 14 days of antibiotic treatment for bacteremia produced by Pseudomonas aeruginosa: a multicenter, randomized… Recruiting
  2023-508441-41-00 Phase IV 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
• Study to assess the safety and efficacy of the SpectraCure P18 System Recruiting
  2022-502285-24-00 Phase I (FiH) 2 countries SpectraCure AB (publ)
• Pancreatic cancer first-line NALIRIFOX optimization with 5-FU maintenance and role of antibiotics and microbiota exploration in second-line … Recruiting
  2024-517766-41-00 Phase II 1 country Association Gercor
• Preoperative Antibiotics for Mild or Moderate Acute Cholecystitis (POMMAC): A Non-inferiority, Open-label, Randomized Controlled Trial – Stu… Recruiting
  2024-515958-24-00 Phase III 1 country HUS-Yhtymae
• REINFORCE – Reducing infection-related readmissions following cystectomy. Recruiting
  2024-514312-27-00 Phase IV 1 country Rigshospitalet
• Influence of antibiotic treatment on the normal flora and the presence of resistance genes in known carriers of ESBL and VRE Recruiting
  2024-517434-17-01 Phase IV 1 country Region Uppsala
• Comparison of Two Antibiotic Regimens for the Treatment of Early Airways Infection With PA in Adults With Bronchiectasis Recruiting
  2023-504755-26-00 Phase II 1 country Centre Hospitalier Intercommunal Creteil
• Short course antibiotic treatment of Gram-negative bacteremia: A multicenter, randomized, non-blinded, non-inferiority interventional study Recruiting
  2024-514900-16-00 Phase IV 1 country Region Hovedstaden
• Efficacy and safety of different antimicrobial DURATions for the treatment of Infections associated with Osteosynthesis Material implanted a… Recruiting
  2023-508442-18-00 Phase III 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
• SAVE- oral antibiotics for treatment of vertebral osteomyelitis Recruiting
  2023-507617-96-01 Phase IV 1 country Rigshospitalet
• Alternative antibiotics to multidrug-resistant UTIs Recruiting
  2024-513294-41-00 Phase IV 1 country Region Skane
• Pharmacokinetics of antibiotics in cerebrospinal fluid of children with malignant brain tumors – a pilot study Recruiting
  2024-518808-43-00 Phase I 1 country Medical University Of Vienna
• Study to treat adult patients with Very High-Risk T-cell Acute Lymphoblastic Leukemia (ALL) with Daratumumab in addition to the National ALL… Ended
  2024-511627-34-00 Phase II 1 country Fondazione Gimema Franco Mandelli Onlus
• A single blind, placebo controlled, single center, randomized controlled pilot study to assess if low dose ciprofloxacin can induce antimicr… Ended
  2023-506205-18-00 Phase II 1 country Institute Of Tropical Medicine
• COTRIVAP - Efficacy of cotrimoxazole as a de-escalation treatment of Ventilator-Associated Pneumonia in intensive care unit Ended
  2023-505108-52-00 Phase III 1 country Assistance Publique Hopitaux De Paris

Showing 1–23 of 23 trials